History of poliomyelitis Hospital, successfully cultivated the poliovirus in human tissue. This significant breakthrough ultimately allowed for the development of the polio vaccines. Enders and his colleagues, Thomas H. Weller and Frederick C. Robbins, were recognized for their labors with the Nobel Prize in 1954. Two vaccines are used throughout the world to combat polio. The first was developed by Jonas Salk, first tested in 1952, and announced to the world by Salk on April 12, 1955. The Salk vaccine, or "inactivated poliovirus vaccine" (IPV), consists of an injected dose of killed poliovirus. In 1954, the vaccine was tested for its ability to
Salk Hall Roosevelt's Public Works Administration. The 225-bed hospital was originally part of the Medical Center associated with the University and was intended to be used primarily to treat communicable diseases. However, when antibiotics virtually eliminated the need to quarantine patients, the building had become a financial burden on the city. Therefore, in September 1949, work began on remodeling the building, and it temporarily housed Pitt's School of Public Health. In October 1957, the Municipal Hospital was formally acquired from the city for $1.3 million ($ million today) and renamed Jonas Salk Hall. For a time, the upper floors of the building